Your browser doesn't support javascript.
loading
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters, S; Pujol, J-L; Dafni, U; Dómine, M; Popat, S; Reck, M; Andrade, J; Becker, A; Moro-Sibilot, D; Curioni-Fontecedro, A; Molinier, O; Nackaerts, K; Insa Mollá, A; Gervais, R; López Vivanco, G; Madelaine, J; Mazieres, J; Faehling, M; Griesinger, F; Majem, M; González Larriba, J L; Provencio Pulla, M; Vervita, K; Roschitzki-Voser, H; Ruepp, B; Mitchell, P; Stahel, R A; Le Pechoux, C; De Ruysscher, D.
Afiliación
  • Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; Lausanne University, Lausanne, Switzerland.
  • Pujol JL; Thoracic Oncology Unit, Hopital Arnaud de Villeneuve, Montpellier, France.
  • Dafni U; National and Kapodistrian University of Athens, Athens, Greece; Frontier Science Foundation-Hellas, Athens, Greece.
  • Dómine M; Hospital Universitario Fundacion Jimenez Díaz (IIS-FJD), Madrid, Spain.
  • Popat S; Medicine, Royal Marsden Hospital, London, UK.
  • Reck M; Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Andrade J; Medical Oncology, Hospital Virgen De La Salud, Toledo, Spain.
  • Becker A; Department of Pulmonology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Moro-Sibilot D; Thoracic Oncology Unit, Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.
  • Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
  • Molinier O; Department of Respiratory Disease, Centre Hospitalier - Le Mans, Le Mans, France.
  • Nackaerts K; Department of Pulmonology, Respiratory Oncology Unit, KU Leuven, Leuven, Belgium.
  • Insa Mollá A; Medical Oncology, Hospital Clínico Universitario De Valencia, Valencia, Spain.
  • Gervais R; Medical Oncology, Centre François Baclesse, Caen, France.
  • López Vivanco G; Medical Oncology, Hospital Universitario Cruces, Barakaldo, Spain.
  • Madelaine J; Thoracic Oncology Unit, Centre Hospitalier Universitaire Caen Normandie, Caen, France.
  • Mazieres J; Thoracic Oncology, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
  • Faehling M; Klinikum Esslingen, Esslingen, Germany.
  • Griesinger F; Pius-Hospital Oldenburg, Oldenburg, Germany.
  • Majem M; Hospital De La Santa Creu I Sant Pau, Barcelona, Spain.
  • González Larriba JL; Hospital Clínico San Carlos, Madrid, Spain.
  • Provencio Pulla M; Hospital Puerta de Hierro, Madrid, Spain.
  • Vervita K; Frontier Science Foundation-Hellas, Athens, Greece.
  • Roschitzki-Voser H; Coordinating Office, European Thoracic Oncology Platform, Bern, Switzerland.
  • Ruepp B; Coordinating Office, European Thoracic Oncology Platform, Bern, Switzerland.
  • Mitchell P; Olivia Newton-John Cancer Centre, Austin Hospital (VIC), Melbourne, Australia.
  • Stahel RA; Coordinating Office, European Thoracic Oncology Platform, Bern, Switzerland. Electronic address: Rolf.Stahel@etop-eu.org.
  • Le Pechoux C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.
  • De Ruysscher D; Maastricht University Medical Center, Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht, Netherlands.
Ann Oncol ; 33(1): 67-79, 2022 01.
Article en En | MEDLINE | ID: mdl-34562610
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Nivolumab / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article